Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Harvard Bioscience, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.01 | $0.04 | $0.02 |
| Q2 2025 | 1 | $0.03 | $0.04 | $0.04 |
| Q3 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2025 | 1 | $0.05 | $0.06 | $0.06 |
Harvard Bioscience, Inc. Earnings Date And Information
Harvard Bioscience, Inc. last posted its earnings results on Wednesday, March 12th, 2025. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. The company had revenue of 24.56 M for the quarter and had revenue of 94.14 M for the year. Harvard Bioscience, Inc. has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -2.41. Harvard Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Harvard Bioscience, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2025 | Q4 2024 | $0.05 | $0.00 | -0.05 | N/A | $24.56 M |
| 11/08/2024 | Q3 2024 | N/A | -$0.11 | N/A | $23.70 M | $21.97 M |
| 08/08/2024 | Q2 2024 | $0.05 | -$0.07 | -0.12 | $26.40 M | $23.10 M |
| 05/07/2024 | Q1 2024 | $0.02 | -$0.11 | -0.13 | N/A | $24.51 M |
| 03/07/2024 | Q4 2023 | $0.05 | -$0.04 | -0.09 | N/A | $28.15 M |
| 11/07/2023 | Q3 2023 | $0.04 | -$0.03 | -0.07 | $28.02 M | $25.36 M |
| 08/08/2023 | Q2 2023 | $0.05 | -$0.02 | -0.07 | $29.50 M | $28.76 M |
| 04/26/2023 | Q1 2023 | N/A | $0.01 | N/A | N/A | $29.98 M |
| 03/09/2023 | Q4 2022 | $0.03 | -$0.04 | -0.07 | N/A | $28.43 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.08 | N/A | $28.87 M | $26.92 M |
| 08/04/2022 | Q2 2022 | N/A | $0.06 | N/A | $30.49 M | $29.21 M |
| 05/04/2022 | Q1 2022 | $0.05 | -$0.17 | -0.22 | N/A | $28.78 M |
| 03/11/2022 | Q4 2021 | N/A | $0.02 | N/A | N/A | $33.06 M |
| 11/05/2021 | Q3 2021 | N/A | -$0.00 | N/A | $27.91 M | $29.66 M |
| 08/06/2021 | Q2 2021 | N/A | -$0.01 | N/A | $27.67 M | $29.20 M |
| 05/07/2021 | Q1 2021 | N/A | -$0.02 | N/A | N/A | $26.99 M |
| 03/12/2021 | Q4 2020 | N/A | -$0.02 | N/A | N/A | $30.98 M |
| 11/06/2020 | Q3 2020 | N/A | -$0.03 | N/A | $24.05 M | $24.04 M |
| 08/10/2020 | Q2 2020 | N/A | -$0.04 | N/A | $22.20 M | $23.31 M |
| 05/08/2020 | Q1 2020 | N/A | -$0.12 | N/A | N/A | $23.77 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Harvard Bioscience, Inc. Earnings: FAQ's
Harvard Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based offlast year's report dates.
In the previous quarter, Harvard Bioscience, Inc. (:HBIO) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.05 by $0.01.
The conference call for Harvard Bioscience, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Harvard Bioscience, Inc.'s latest earnings report can be read online.
Harvard Bioscience, Inc. (:HBIO) has a recorded annual revenue of $94.14 M.
Harvard Bioscience, Inc. (:HBIO) has a recorded net income of $-12,405,000.Harvard Bioscience, Inc. has generated $-0.28 earnings per share over the last four quarters.
Harvard Bioscience, Inc. (:HBIO) has a price-to-earnings ratio of -2.41 and price/earnings-to-growth ratio is -0.2.